nach oben

Critical Care

Erschienen in:

01.04.2010 | Review

Role of CD14 in lung inflammation and infection

verfasst von: Adam Anas, Tom van der Poll, Alex F de Vos

Erschienen in: Critical Care | Ausgabe 2/2010

Einloggen, um Zugang zu erhalten

Abstract

This article is one of ten reviews selected from the Yearbook of Intensive Care and Emergency Medicine 2010 (Springer Verlag) and co-published as a series in Critical Care. Other articles in the series can be found online at http://ccforum.com/series/yearbook. Further information about the Yearbook of Intensive Care and Emergency Medicine is available from http://www.springer.com/series/2855.

Basu S, Fenton MJ: Toll-like receptors: function and roles in lung disease. Am J Physiol Lung Cell Mol Physiol. 2004, 286: L887-L892. 10.1152/ajplung.00323.2003.CrossRefPubMed

Wright SD: CD14 and innate recognition of bacteria. J Immunol. 1995, 155: 6-8.PubMed

LeVan TD, Von Essen S, Romberger DJ, et al: Polymorphisms in the CD14 gene associated with pulmonary function in farmers. Am J Respir Crit Care Med. 2005, 171: 773-779. 10.1164/rccm.200404-530OC.CrossRefPubMed

Kim JI, Lee CJ, Jin MS, et al: Crystal structure of CD14 and its implications for lipopolysaccharide signaling. J Biol Chem. 2005, 280: 11347-11351. 10.1074/jbc.M414607200.CrossRefPubMed

Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC: CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science. 1990, 249: 1431-1433. 10.1126/science.1698311.CrossRefPubMed

Martin TR, Rubenfeld GD, Ruzinski JT, et al: Relationship between soluble CD14, lipopolysaccharide binding protein, and the alveolar inflammatory response in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 1997, 155: 937-944.CrossRefPubMed

Beutler B, Rietschel ET: Innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol. 2003, 3: 169-176. 10.1038/nri1004.CrossRefPubMed

Knapp S, Florquin S, Golenbock DT, Poll Van der T: Pulmonary lipopolysaccharide (LPS)-binding protein inhibits the LPS-induced lung inflammation in vivo. J Immunol. 2006, 176: 3189-3195.CrossRefPubMed

Pugin J, Schurer-Maly CC, Leturcq D, et al: Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc Natl Acad Sci USA. 1993, 90: 2744-2748. 10.1073/pnas.90.7.2744.PubMedCentralCrossRefPubMed

10.

Kitchens RL, Thompson PA: Modulatory effects of sCD14 and LBP on LPS-host cell interactions. J Endotoxin Res. 2005, 11: 225-229.CrossRefPubMed

11.

Park BS, Song DH, Kim HM, et al: The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature. 2009, 458: 1191-1195. 10.1038/nature07830.CrossRefPubMed

12.

Akira S, Uematsu S, Takeuchi O: Pathogen recognition and innate immunity. Cell. 2006, 124: 783-801. 10.1016/j.cell.2006.02.015.CrossRefPubMed

13.

Jiang Z, Georgel P, Du X, et al: CD14 is required for MyD88-independent LPS signaling. Nat Immunol. 2005, 6: 565-570. 10.1038/ni1207.CrossRefPubMed

14.

Kurt-Jones EA, Popova L, Kwinn L, et al: Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol. 2000, 1: 398-401. 10.1038/80833.CrossRefPubMed

15.

Chaby R, Garcia-Verdugo I, Espinassous Q, Augusto : LA Interactions between LPS and lung surfactant proteins. J Endotoxin Res. 2005, 11: 181-185.CrossRefPubMed

16.

Senft AP, Korfhagen TR, Whitsett JA, Shapiro SD, LeVine AM: Surfactant protein-D regulates soluble CD14 through matrix metalloproteinase-12. J Immunol. 2005, 174: 4953-4959.CrossRefPubMed

17.

Pugin J, Heumann ID, Tomasz A, et al: CD14 is a pattern recognition receptor. Immunity. 1994, 1: 509-516. 10.1016/1074-7613(94)90093-0.CrossRefPubMed

18.

Schroder NW, Morath S, Alexander C, et al: Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. J Biol Chem. 2003, 278: 15587-15594. 10.1074/jbc.M212829200.CrossRefPubMed

19.

Dziarski R, Gupta D: Peptidoglycan recognition in innate immunity. J Endotoxin Res. 2005, 11: 304-310.CrossRefPubMed

20.

Lee HK, Dunzendorfer S, Soldau K, Tobias PS: Double-stranded RNA-mediated TLR3 activation is enhanced by CD14. Immunity. 2006, 24: 153-163. 10.1016/j.immuni.2005.12.012.CrossRefPubMed

21.

Ishii Y, Wang Y, Haziot A, et al: Lipopolysaccharide binding protein and CD14 interaction induces tumor necrosis factor-alpha generation and neutrophil sequestration in lungs after intratracheal endotoxin. Circ Res. 1993, 73: 15-23.CrossRefPubMed

22.

Smith LS, Kajikawa O, Elson G, et al: Effect of Toll-like receptor 4 blockade on pulmonary inflammation caused by mechanical ventilation and bacterial endotoxin. Exp Lung Res. 2008, 34: 225-243. 10.1080/01902140802022492.CrossRefPubMed

23.

Tasaka S, Ishizaka A, Yamada W, et al: Effect of CD14 blockade on endotoxin-induced acute lung injury in mice. Am J Respir Cell Mol Biol. 2003, 29: 252-258. 10.1165/rcmb.2002-0132OC.CrossRefPubMed

24.

Jeyaseelan S, Chu HW, Young SK, Freeman MW, Worthen GS: Distinct roles of pattern recognition receptors CD14 and Toll-like receptor 4 in acute lung injury. Infect Immun. 2005, 73: 1754-1763. 10.1128/IAI.73.3.1754-1763.2005.PubMedCentralCrossRefPubMed

25.

Knapp S, Wieland CW, Florquin S, et al: Differential roles of CD14 and toll-like receptors 4 and 2 in murine Acinetobacter pneumonia. Am J Respir Crit Care Med. 2006, 173: 122-129. 10.1164/rccm.200505-730OC.CrossRefPubMed

26.

Brass DM, Hollingsworth JW, McElvania-Tekippe E, et al: CD14 is an essential mediator of LPS induced airway disease. Am J Physiol Lung Cell Mol Physiol. 2007, 293: L77-L83. 10.1152/ajplung.00282.2006.CrossRefPubMed

27.

Hollingsworth JW, Cook DN, Brass DM, et al: The role of Toll-like receptor 4 in environmental airway injury in mice. Am J Respir Crit Care Med. 2004, 170: 126-132. 10.1164/rccm.200311-1499OC.CrossRefPubMed

28.

Knapp S, von Aulock S, Leendertse M, et al: Lipoteichoic acid-induced lung inflammation depends on TLR2 and the concerted action of TLR4 and the platelet-activating factor receptor. J Immunol. 2008, 180: 3478-3484.CrossRefPubMed

29.

Dessing MC, Schouten M, Draing C, et al: Role played by Toll-like receptors 2 and 4 in lipoteichoic acid-induced lung inflammation and coagulation. J Infect Dis. 2008, 197: 245-252. 10.1086/524873.CrossRefPubMed

30.

Wieland CW, Florquin S, Maris NA, et al: The MyD88-dependent, but not the MyD88-independent, pathway of TLR4 signaling is important in clearing nontypeable haemophilus influenzae from the mouse lung. J Immunol. 2005, 175: 6042-6049.CrossRefPubMed

31.

Wang X, Moser C, Louboutin JP, et al: Toll-like receptor 4 mediates innate immune responses to Haemophilus influenzae infection in mouse lung. J Immunol. 2002, 168: 810-815.CrossRefPubMed

32.

Frevert CW, Matute-Bello G, Skerrett SJ, et al: Effect of CD14 blockade in rabbits with Escherichia coli pneumonia and sepsis. J Immunol. 2000, 164: 5439-5445.CrossRefPubMed

33.

Lee JS, Frevert CW, Matute-Bello G, et al: TLR-4 pathway mediates the inflammatory response but not bacterial elimination in E. coli pneumonia. Am J Physiol Lung Cell Mol Physiol. 2005, 289: L731-L738. 10.1152/ajplung.00196.2005.CrossRefPubMed

34.

Jeyaseelan S, Young SK, Fessler MB, et al: Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF)-mediated signaling contributes to innate immune responses in the lung during Escherichia coli pneumonia. J Immunol. 2007, 178: 3153-3160.CrossRefPubMed

35.

Cai S, Zemans RL, Young SK, Worthen GS, Jeyaseelan S: Myeloid differentiation protein-2-dependent and -independent neutrophil accumulation during Escherichia coli pneumonia. Am J Respir Cell Mol Biol. 2009, 40: 701-709. 10.1165/rcmb.2008-0152OC.PubMedCentralCrossRefPubMed

36.

Ramphal R, Balloy V, Jyot J, et al: Control of Pseudomonas aeruginosa in the lung requires the recognition of either lipopolysaccharide or flagellin. J Immunol. 2008, 181: 586-592.PubMedCentralCrossRefPubMed

37.

Reddi K, Phagoo SB, Anderson KD, Warburton D: Burkholderia cepacia-induced IL-8 gene expression in an alveolar epithelial cell line: signaling through CD14 and mitogen-activated protein kinase. Pediatr Res. 2003, 54: 297-305. 10.1203/01.PDR.0000076661.85928.1D.CrossRefPubMed

38.

Branger J, Knapp S, Weijer S, et al: Role of Toll-like receptor 4 in gram-positive and gram-negative pneumonia in mice. Infect Immun. 2004, 72: 788-794. 10.1128/IAI.72.2.788-794.2004.PubMedCentralCrossRefPubMed

39.

Wiersinga WJ, Wieland CW, Dessing MC, et al: Toll-like receptor 2 impairs host defense in gram-negative sepsis caused by Burkholderia pseudomallei (Melioidosis). PLoS Med. 2007, 4: e248-10.1371/journal.pmed.0040248.PubMedCentralCrossRefPubMed

40.

Wiersinga WJ, de Vos AF, Wieland CW, et al: CD14 impairs host defense against gram-negative sepsis caused by Burkholderia pseudomallei in mice. J Infect Dis. 2008, 198: 1388-1397. 10.1086/592220.CrossRefPubMed

41.

Dessing MC, Knapp S, Florquin S, De Vos AF, Poll Van der T: CD14 facilitates invasive respiratory tract infection by Streptococcus pneumoniae. Am J Respir Crit Care Med. 2007, 175: 604-611. 10.1164/rccm.200606-824OC.CrossRefPubMed

42.

Knapp S, Wieland CW, Murawskian 't Veer C, et al: Toll-like receptor 2 plays a role in the early inflammatory response to murine pneumococcal pneumonia but does not contribute to antibacterial defense. J Immunol. 2004, 172: 3132-3138.CrossRefPubMed

43.

Rijneveld AW, Weijer S, Florquin S, et al: Improved host defense against pneumococcal pneumonia in platelet-activating factor receptor-deficient mice. J Infect Dis. 2004, 189: 711-716. 10.1086/381392.CrossRefPubMed

44.

Wieland CW, Windt Van der GJ, Wiersinga WJ, Florquin S, Poll Van der T: CD14 contributes to pulmonary inflammation and mortality during murine tuberculosis. Immunology. 2008, 125: 272-279. 10.1111/j.1365-2567.2008.02840.x.PubMedCentralCrossRefPubMed

45.

Reiling N, Holscher C, Fehrenbach A, et al: Toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis. J Immunol. 2002, 169: 3480-3484.CrossRefPubMed

46.

Abel B, Thieblemont N, Quesniaux VJ, et al: Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice. J Immunol. 2002, 169: 3155-3162.CrossRefPubMed

47.

Drennan MB, Nicolle D, Quesniaux VJ, et al: Toll-like receptor 2-deficient mice succumb to Mycobacterium tuberculosis infection. Am J Pathol. 2004, 164: 49-57.PubMedCentralCrossRefPubMed

48.

Branger J, Leemans JC, Florquin S, et al: Toll-like receptor 4 plays a protective role in pulmonary tuberculosis in mice. Int Immunol. 2004, 16: 509-516. 10.1093/intimm/dxh052.CrossRefPubMed

49.

Murawski MR, Bowen GN, Cerny AM, et al: Respiratory syncytial virus activates innate immunity through Toll-like receptor 2. J Virol. 2009, 83: 1492-1500. 10.1128/JVI.00671-08.PubMedCentralCrossRefPubMed

50.

Dessing MC, Sluijs Van der KF, Florquin S, Poll Van der T: CD14 plays a limited role during influenza A virus infection in vivo. Immunol Lett. 2007, 113: 47-51. 10.1016/j.imlet.2007.07.016.CrossRefPubMed

Titel: Role of CD14 in lung inflammation and infection
verfasst von: Adam Anas
Tom van der Poll
Alex F de Vos
Publikationsdatum: 01.04.2010
Verlag: BioMed Central
Erschienen in: Critical Care / Ausgabe 2/2010
Elektronische ISSN: 1364-8535
DOI: https://doi.org/10.1186/cc8850

Neu im Fachgebiet AINS

23.04.2024 | Appendizitis | Nachrichten

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren

Springer Medizin

Role of CD14 in lung inflammation and infection

Abstract

Neu im Fachgebiet AINS

Hinter dieser Appendizitis steckte ein Erreger

Ärztliche Empathie hilft gegen Rückenschmerzen

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

S3-Leitlinie zu Pankreaskrebs aktualisiert

Update AINS

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2010

Activated protein C ameliorates coagulopathy but does not influence outcome in lethal H1N1 influenza: a controlled laboratory study

Wet lungs, broken hearts and difficult therapies after subarachnoid hemorrhage

A plea for balanced reporting

Vacuum-assisted closure device in intensive care unit patients and dissemination of Gram-negative bacteria

Effects of different fibrinogen concentrations on blood loss and coagulation parameters in a pig model of coagulopathy with blunt liver injury

Prolonged mechanical ventilation in a respiratory-care setting: a comparison of outcome between tracheostomized and translaryngeal intubated patients

Neu im Fachgebiet AINS

Hinter dieser Appendizitis steckte ein Erreger

Ärztliche Empathie hilft gegen Rückenschmerzen

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

S3-Leitlinie zu Pankreaskrebs aktualisiert

Update AINS